Drug Profile
AMZ 0026
Alternative Names: Abavca; AMZ 0026-H; AMZ-0026; AZC 0027; PerthonLatest Information Update: 18 Sep 2015
Price :
$50
*
At a glance
- Originator Advanced Plant Pharmaceuticals
- Developer Amazon Biotech
- Class Antivirals
- Mechanism of Action Immunomodulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
- Discontinued Breast cancer; Coronavirus infections; Lyme disease
Most Recent Events
- 18 Sep 2015 No recent reports on development identified - Phase-I/II for HIV infections in USA and India (PO)
- 16 Mar 2012 Phase-I/II development is ongoing in USA
- 27 Feb 2012 Discontinued - Preclinical for Breast cancer in USA (PO)